Evans John M.
CEO
Sale 10b5-1
- Shares
- 25,000
- Price
- $23.98
- Value
- $599,595
SEC EDGAR · Forms 3/4/5Updated through Oct 30, 2026•45 filings
BEAM
Beam Therapeutics Inc.
Net sales of $1.2M over the last 3 months
1 seller account for the net balance. There is no cluster of three distinct buyers within 30 days. We found no CEO/CFO purchases over 12 months.
How to read this signal
Only open-market P purchases and S sales count toward the signal. Vesting, options, taxes and gifts remain in the source data but do not trigger alerts. Rule 10b5-1 trades are shown as informational.
3-month balance
−$1,188,745
0 buyers · 1 sellers
12-month purchases
$0.00
0 distinct insiders
12-month sales
$18,093,959
6 distinct insiders
Highlighted alerts
4
22 Rule 10b5-1 trades treated as informational
Buying cluster · 30 days
Fewer than three distinct buyers
CEO/CFO purchases · 12 months
No executive purchases found
Get BEAM insider trades by API
The same filtered trades as JSON for your scripts, alerts or AI agent, for 5,500+ US companies — plus sentiment, news, financials and breakout setups. Free · every API · 1,000 requests a month · no card required.
BEAM overview: breakout setup, X sentiment and insiders in one page →
Form 4 raw → Raspberry
The value is in what we do not call a signal.
The SEC XML stores every transaction. Raspberry keeps that evidence, reads the footnotes and separates voluntary open-market activity from vesting, option exercises, gifts, tax withholding, stock purchase and dividend reinvestment plans and pre-programmed 10b5-1 trades.
88
Raw transactions
Everything returned by the filing
26
Voluntary view
P/S trades after deterministic checks
62
Administrative noise
Stored, never alerted
61
10b5-1
Shown as informational
SEC ownership XML facts
- Code
- S
- Shares
- 187
- Price
- $24.41
- Footnotes
- 1
These shares of common stock were automatically sold in a non-discretionary transaction by the Reporting Person in order to cover tax withholding obligations upon the vesting of certain restricted stock units granted to the Reporting Person under the Beam Therapeutics Inc. 2019 Equity Incentive Plan on September 30, 2024. The sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 9, 2024.
Raspberry interpretation
Informational — no alert
Reason: tax_withholding. The filing footnotes identify tax withholding. The trade is reported under a Rule 10b5-1 plan.
Recent transactions
Voluntary purchases and sales; administrative noise stays hidden.
Evans John M.
CEO
Sale 10b5-1
- Shares
- 25,000
- Price
- $23.57
- Value
- $589,150
Simon Amy
Chief Medical Officer
Sale 10b5-1
- Shares
- 16,667
- Price
- $25.74
- Value
- $429,037
Evans John M.
CEO
Sale 10b5-1
- Shares
- 1,900
- Price
- $34.84
- Value
- $66,203
Evans John M.
CEO
Sale 10b5-1
- Shares
- 23,100
- Price
- $34.26
- Value
- $791,482
Evans John M.
CEO
Sale 10b5-1
- Shares
- 11,579
- Price
- $35.91
- Value
- $415,824
Evans John M.
CEO
Sale 10b5-1
- Shares
- 13,421
- Price
- $35.13
- Value
- $471,528
FMR LLC
10% owner
SaleAlert
- Shares
- 251,488
- Price
- $35.26
- Value
- $8,867,467
FMR LLC
10% owner
SaleAlert
- Shares
- 33,372
- Price
- $35.12
- Value
- $1,172,025
Evans John M.
CEO
Sale 10b5-1
- Shares
- 25,000
- Price
- $22.76
- Value
- $569,085
Evans John M.
CEO
Sale 10b5-1
- Shares
- 25,000
- Price
- $22.37
- Value
- $559,230
Ciaramella Giuseppe
President
Sale 10b5-1
- Shares
- 35,000
- Price
- $32.00
- Value
- $1,120,042
Evans John M.
CEO
Sale 10b5-1
- Shares
- 2,906
- Price
- $29.00
- Value
- $84,274
Evans John M.
CEO
Sale 10b5-1
- Shares
- 22,094
- Price
- $28.27
- Value
- $624,673
Evans John M.
CEO
Sale 10b5-1
- Shares
- 8,667
- Price
- $29.74
- Value
- $257,781
Evans John M.
CEO
Sale 10b5-1
- Shares
- 16,333
- Price
- $29.19
- Value
- $476,801
Cavanagh Bethany J
SVP, Finance and Treasurer
Sale 10b5-1
- Shares
- 6,198
- Price
- $35.00
- Value
- $216,933
Bellon Christine
Chief Legal Officer
Sale 10b5-1
- Shares
- 1,371
- Price
- $34.00
- Value
- $46,614
Cavanagh Bethany J
SVP, Finance and Treasurer
Sale 10b5-1
- Shares
- 3,034
- Price
- $30.12
- Value
- $91,384
Bellon Christine
Chief Legal Officer
Sale 10b5-1
- Shares
- 559
- Price
- $35.40
- Value
- $19,788
Bellon Christine
Chief Legal Officer
Sale 10b5-1
- Shares
- 15,959
- Price
- $34.72
- Value
- $554,068
Bellon Christine
Chief Legal Officer
Sale 10b5-1
- Shares
- 2,111
- Price
- $33.62
- Value
- $70,976
FMR LLC
10% owner
SaleAlert
- Shares
- 459
- Price
- $26.68
- Value
- $12,246
Evans John M.
CEO
Sale 10b5-1
- Shares
- 25,000
- Price
- $24.63
- Value
- $615,668
Evans John M.
CEO
Sale 10b5-1
- Shares
- 25,000
- Price
- $24.51
- Value
- $612,655
FMR LLC
10% owner
SaleAlert
- Shares
- 48,374
- Price
- $20.50
- Value
- $991,667
| Date | Insider | Transaction | Shares | Price | Value | Reading |
|---|---|---|---|---|---|---|
| Oct 16, 2026 | Evans John M. CEO | Sale | 25,000 | $23.98 | $599,595 | |
| Oct 15, 2026 | Evans John M. CEO | Sale | 25,000 | $23.57 | $589,150 | |
| Jul 27, 2026 | Simon Amy Chief Medical Officer | Sale | 16,667 | $25.74 | $429,037 | |
| Jun 30, 2026 | Evans John M. CEO | Sale | 1,900 | $34.84 | $66,203 | |
| Jun 30, 2026 | Evans John M. CEO | Sale | 23,100 | $34.26 | $791,482 | |
| Jun 29, 2026 | Evans John M. CEO | Sale | 11,579 | $35.91 | $415,824 | |
| Jun 29, 2026 | Evans John M. CEO | Sale | 13,421 | $35.13 | $471,528 | |
| Jun 26, 2026 | FMR LLC 10% owner | Sale | 251,488 | $35.26 | $8,867,467 | |
| Jun 25, 2026 | FMR LLC 10% owner | Sale | 33,372 | $35.12 | $1,172,025 | |
| Mar 31, 2026 | Evans John M. CEO | Sale | 25,000 | $22.76 | $569,085 | |
| Mar 30, 2026 | Evans John M. CEO | Sale | 25,000 | $22.37 | $559,230 | |
| Feb 24, 2026 | Ciaramella Giuseppe President | Sale | 35,000 | $32.00 | $1,120,042 | |
| Jan 30, 2026 | Evans John M. CEO | Sale | 2,906 | $29.00 | $84,274 | |
| Jan 30, 2026 | Evans John M. CEO | Sale | 22,094 | $28.27 | $624,673 | |
| Jan 29, 2026 | Evans John M. CEO | Sale | 8,667 | $29.74 | $257,781 | |
| Jan 29, 2026 | Evans John M. CEO | Sale | 16,333 | $29.19 | $476,801 | |
| Jan 22, 2026 | Cavanagh Bethany J SVP, Finance and Treasurer | Sale | 6,198 | $35.00 | $216,933 | |
| Jan 22, 2026 | Bellon Christine Chief Legal Officer | Sale | 1,371 | $34.00 | $46,614 | |
| Jan 20, 2026 | Cavanagh Bethany J SVP, Finance and Treasurer | Sale | 3,034 | $30.12 | $91,384 | |
| Jan 15, 2026 | Bellon Christine Chief Legal Officer | Sale | 559 | $35.40 | $19,788 | |
| Jan 15, 2026 | Bellon Christine Chief Legal Officer | Sale | 15,959 | $34.72 | $554,068 | |
| Jan 15, 2026 | Bellon Christine Chief Legal Officer | Sale | 2,111 | $33.62 | $70,976 | |
| Oct 27, 2025 | FMR LLC 10% owner | Sale | 459 | $26.68 | $12,246 | |
| Oct 02, 2025 | Evans John M. CEO | Sale | 25,000 | $24.63 | $615,668 | |
| Oct 01, 2025 | Evans John M. CEO | Sale | 25,000 | $24.51 | $612,655 | |
| Jul 30, 2025 | FMR LLC 10% owner | Sale | 48,374 | $20.50 | $991,667 |
“Alert” means a voluntary, unscheduled transaction according to the filing; it is not an investment recommendation. Official source: SEC EDGAR.